Immunophenotypic spectrum and mutational landscape of <scp>EBV</scp> ‐positive inflammatory follicular dendritic cell sarcoma
These findings demonstrate the wide morphological and immunophenotypic spectrum of EBV+ IFDCS. Furthermore, variants in chromatin modifier and HRR-related genes may participate in its pathogenesis, and PARP inhibition may represent a potential therapeutic strategy for patients with unresectable disease.
Authors
- Xiaojiang Wang (ORCID: https://orcid.org/0000-0001-7836-4865)
- G. Chen
- L. Lin
- Fangfang Chen (ORCID: https://orcid.org/0000-0002-0854-1667)
- Lihong Chen (ORCID: https://orcid.org/0000-0003-0105-090X)
- Wenfang Zhang (ORCID: https://orcid.org/0000-0002-0042-9689)
- Shu‐Lin Li
- Jian‐Chao Wang
- Chen Wang
- Zi‐Qing Yu
- Mu‐Sheng Chen
- Yan‐Ping Chen
- Xin Chen
- Li‐Hua Zhong
Institutions
- Fujian Medical University (CN)
- Mengchao Hepatobiliary Hospital (CN)
- Fujian Provincial Hospital (CN)
- Fujian Provincial Cancer Hospital (CN)
- Chongqing Cancer Hospital (CN)
Publication Details
- Journal
- Histopathology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1111/his.70097
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00